Table 5 Final diagnosis and outcomes of patients
Case no. | Host factors | Mycological findings | Initial CT scan | Initial IPA diagnosis | Second CT scan | Biopsy | Modified IPA diagnose | Outcomings after antifungal treatment | |
|---|---|---|---|---|---|---|---|---|---|
Serum G/GM (pg/ml, AU/ml) | Positive culture for Aspergillus | ||||||||
1 | MP (253 mg) | 117/0.48 | Aspergillus | Nonspecific | Uncertain | Cavities | NA | Probable IPA | Recovery |
2 | MP (1048 mg) | NA/positive* | Negative | Nonspecific | Uncertain | Cavities | NA | Probable IPA | Improve but died due to discontinue of treatment |
3 | MP (1040 mg) Asthma Prostatic cancer | NA/0.08 | Negative | Nonspecific | Uncertain | Cavities | NA | Possible IPA | Recovery |
4 | MP (1032 mg) COPD | 3820/ positive | Negative | Nonspecific | Uncertain | Cavities | NA | Probable IPA | Recovery |
5 | MP(2360 mg) Asthma | NA/0.31 | Negative | Nonspecific | Uncertain | Cavities | NA | Possible IPA | Recovery |
6 | Postoperative esophagus cancer | NA/NA | Filamentous fungi | Nonspecific | Uncertain | Cavities | NA | Probable IPA | Unknown |
7 | MP (1200 mg) | NA/0.07 | Aspergillus | Nonspecific | Uncertain | Cavities | NA | Probable IPA | Recovery |
8 | None | 269.40/ positive | Aspergillus | Nonspecific | Uncertain | Cavities | NA | Probable IPA | Recovery |
9 | None | NA/negative | NA | Nonspecific | Uncertain | Cavities | Aspergillus | Proven IPA | Recovery |
10 | MP(1200 mg) Asthma | 27.55/positive | NA | Nonspecific | Uncertain | Cavities | NA | Probable IPA | Recovery |